Journal Mobile Options
Table of Contents
Vol. 20, No. 5, 2005
Issue release date: September–October 2005
Section title: Paper
Fetal Diagn Ther 2005;20:442–444
(DOI:10.1159/000087114)

Infiltrative Breast Cancer during Pregnancy and Conservative Surgery

Annane K.a · Bellocq J.-P.b · Brettes J.-P.a · Mathelin C.a
aService de Gynécologie-Obstétrique, Hôpitaux Universitaires de Strasbourg et bService d’Anatomie Pathologique, Hôpital de Hautepierre, Strasbourg, France

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 33.00
Account: USD 23.00

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Paper

Received: 8/30/2004
Accepted: 3/14/2005
Published online: 8/19/2005
Issue release date: September–October 2005

Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 3

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: http://www.karger.com/FDT

Abstract

Mastectomy is considered as the standard therapy for gestational breast cancer. Since radiation therapy is harmful for the fetus, conservative surgery is rarely used during pregnancy. Among 16 patients with gestational breast cancer, 10 and 6 were treated with conservative surgery and mastectomy, respectively. No local recurrences occurred with a median follow-up time of 87 months. Among the 10 patients treated with conservative surgery, 3 chose therapeutic abortion and 7 opted to continue their pregnancy. Concerning these 7 fetuses, there were no congenital anomalies, nor growth restriction. All children were normal physically and neurologically. We concluded that conservative breast surgery may be an alternative to mastectomy in the treatment of gestational breast cancer and is safe for the fetus.

© 2005 S. Karger AG, Basel


  

Author Contacts

Carole Mathelin, MD
Service de Gynécologie-Obstétrique, Hôpitaux Universitaires de Strasbourg
1, place de l’Hôpital
FR–67091 Strasbourg Cedex (France)
Tel. +33 3 8825 8573, Fax +33 3 8825 2448, E-Mail Mathelin@igbmc.u-strasbg.fr

  

Article Information

Received: August 30, 2004
Accepted after revision: March 14, 2005
Number of Print Pages : 3
Number of Figures : 0, Number of Tables : 3, Number of References : 4

  

Publication Details

Fetal Diagnosis and Therapy (Clinical Advances and Basic Research)

Vol. 20, No. 5, Year 2005 (Cover Date: September-October 2005)

Journal Editor: Holzgreve, W. (Basel)
ISSN: 1015–3837 (print), 1421–9964 (Online)

For additional information: http://www.karger.com/fdt


Article / Publication Details

First-Page Preview
Abstract of Paper

Received: 8/30/2004
Accepted: 3/14/2005
Published online: 8/19/2005
Issue release date: September–October 2005

Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 3

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: http://www.karger.com/FDT


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.